GenScript Sponsors Fourth Annual Synthetic Biology Convention

Released on: August 26, 2008, 8:39 pm

Press Release Author: Sally Wang

Industry: Biotech

Press Release Summary: As a player in synthetic biology, GenScript is to be one of
the Sponsors of SB4.0

Press Release Body: PISCATAWAY, N.J., Aug. 27, 2008 - International research
outsourcing company GenScript Corporation announces its support and sponsorship of
SB4.0, the fourth annual international convention dedicated to the field of
synthetic biology. SB4.0 is to be held on October 10-12th, 2008 at Hong Kong\'s
University of Science and Technology.

Synthetic biology is a new branch of bioengineering emphasizing technologies that
involve the synthesis of important biological molecules, such as DNA. It has
applications in bioenergy, drug production, medicine, and the development of new
materials. There have been three successful international synthetic biology
conferences in the past: SB1.0 at MIT, SB2.0 at UC Berkeley, and SB3.0 at ETH
Zurich, respectively.

GenScript has been a leader in the field of synthetic biology for many years. Many
of its products and services involve gene synthesis, peptide design and synthesis,
protein expression and refolding, large-scale protein production, large-scale
polyclonal and monoclonal antibody production, express polyclonal antibody
production, affinity purification, conjugation, fragmentation, and immunoassay
development. GenScript also offers early drug discovery services, mammalian cell
line development, immunoassay development, and patch clamp hERG safety testing.
Furthermore, GenScript's sensitive and efficient One-Step WesternT Kits, One-Step
IP-Western Kits, and specialized PCR reagents have gradually gained recognition and
favor in both industry settings and in the academic world.

###

http://sb4.biobricks.org/




Web Site: http://www.genscript.com/index.html

Contact Details: For further information, please contact:
Sally Wang, Director of Sales
GENSCRIPT CORPORATION
(877) 436-7274
sallyw@GenScript.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •